The ACTION Trial: DOACs in Hospitalized Patients with COVID-19
Background: Patients hospitalized with COVID-19 are at increased risk for both arterial and venous thromboembolic disease. Multiple recent trials have investigated the efficacy of therapeutic or standard prophylactic anticoagulation in...
Marco Torres |